March 13, 2025

Announcement of Collaboration with Axcelead Drug Discovery Partners, a Drug Discovery Solution Provider

VitroVo, Inc. (hereinafter referred to as “VitroVo”) is pleased to announce the commencement of a collaboration with Axcelead Drug Discovery Partners, Inc. (Headquarters: Fujisawa, Kanagawa; Representative Director, President and CEO: Kengo Okada, PhD) (hereinafter referred to as “Axcelead DDP”).

Background and Purpose of the Collaboration

　VitroVo provides contract research service for in vitro compound testing, leveraging extensive experience in compound evaluation centered on microelectrode array (MEA) measurement technology. We design study plans tailored to the needs of our clients, primarily pharmaceutical companies, and provide highly precise compound testing services.
While the outsourcing of drug discovery research has long been a trend, the transition has been progressing more rapidly than anticipated. Consequently, in the pharmaceutical industry, the need to respond swiftly to the increasingly diverse outsourcing demands is growing. To adapt to these changes in the external environment and to expand opportunities for contract research services from Japan domestic and international pharmaceutical companies, we have initiated this collaboration with Axcelead DDP.

Future Outlook

　Through this collaboration, Axcelead DDP and VitroVo aim to expand opportunities to provide services to new clients, including those overseas. Furthermore, by utilizing the expanded network and sales infrastructure resulting from our service offerings, we plan to enter new markets.

About Axcelead DDP

　Axcelead DDP is Japan’s first drug discovery solution provider established in July 2017 by inheriting the drug discovery platform from Takeda Pharmaceutical. Screening, medicinal chemistry, pharmacology/biology, DMPK, and safety research functions are integrated into one center with a state-of-the-art research base and original compound library. Together with the most advanced AI capability integration to Axcelead DDP’s service, Axcelead DDP creates high quality drug candidates rapidly. By leveraging these strengths, Axcelead DDP provides solutions to various challenges faced in the process from exploratory research to clinical in drug discovery. For more information, please visit https://www.axcelead.com/